Basem Al-Shayeb is the Co-founder and chief technology officer of Amber Bio, as well as researcher at the Innovative Genomics Institute. He led the discovery of the largest known bacteriophages, the smallest CRISPR gene editing systems, and Borgs in methane-oxidizing archaea

Al-Shayeb holds a PhD in Microbiology from the University of California, Berkeley. He completed B.S. in microbiology as well as Genetics, Cell Biology, and Development from University of Minnesota- Twin Cities.